HemaSphere
(Jun 2022)
P883: TARGETING CALCINEURIN/NFATC1 SIGNALING SENSITIZES PROTEASOME INHIBITION TREATMENT IN MULTIPLE MYELOMA
- J. Zhang,
- X. Luo,
- T. Xia,
- K. C. Cheng,
- M. H. Ng
Affiliations
- J. Zhang
- 1 Blood Cancer Cytogenetics and Genomics Laboratory, Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China
- X. Luo
- 1 Blood Cancer Cytogenetics and Genomics Laboratory, Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China
- T. Xia
- 1 Blood Cancer Cytogenetics and Genomics Laboratory, Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China
- K. C. Cheng
- 1 Blood Cancer Cytogenetics and Genomics Laboratory, Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China
- M. H. Ng
- 1 Blood Cancer Cytogenetics and Genomics Laboratory, Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000846408.90988.ee
- Journal volume & issue
-
Vol. 6
pp.
775
– 776
WeChat QR code